Electronic patient-reported symptom monitoring in patients recovering from ambulatory minimally invasive gynecologic surgery: A prospective pilot study

[1]  G. Elwyn,et al.  Implications for Telehealth in a Postpandemic Future: Regulatory and Privacy Issues. , 2020, JAMA.

[2]  Daniel M. Stein,et al.  Ambulatory cancer care electronic symptom self-reporting (ACCESS) for surgical patients: a randomised controlled trial protocol , 2019, BMJ Open.

[3]  E. Basch,et al.  Cost-Effectiveness of Web-Based Patient-Reported Outcome Surveillance in Patients With Lung Cancer. , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  J. Temel,et al.  Pilot randomized trial of an electronic symptom monitoring intervention for hospitalized patients with cancer , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  C. Letellier,et al.  Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients , 2017, Journal of the National Cancer Institute.

[6]  M. Kris,et al.  Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment , 2017, JAMA.

[7]  E. Basch,et al.  Electronic patient-reported outcomes from home in patients recovering from major gynecologic cancer surgery: A prospective study measuring symptoms and health-related quality of life. , 2016, Gynecologic oncology.

[8]  Deborah Schrag,et al.  Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  D. Travers,et al.  Why do patients with cancer visit emergency departments? Results of a 2008 population study in North Carolina. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Qiuling Shi,et al.  Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  C. Cleeland,et al.  A computerized telephone monitoring and alert system to reduce postoperative symptoms: A randomized trial , 2008 .

[12]  David Artz,et al.  Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  M. Somerfield,et al.  American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  C. Cleeland.  Symptom burden: multiple symptoms and their impact as patient-reported outcomes. , 2007, Journal of the National Cancer Institute. Monographs.

[15]  Kai Lin,et al.  Application of Information Technology: Evaluation of an Online Platform for Cancer Patient Self-reporting of Chemotherapy Toxicities , 2007, J. Am. Medical Informatics Assoc..

[16]  M. Kris,et al.  Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. , 2006, The Lancet. Oncology.

[17]  Nandita Mitra,et al.  Patient online self-reporting of toxicity symptoms during chemotherapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  E. Basch,et al.  An Evidence-Based Systematic Review of Echinacea (E. angustifolia DC, E. pallida, E. purpurea) by the Natural Standard Research Collaboration , 2005 .

[19]  Lawrence B Marks,et al.  Normal tissue effects: reporting and analysis. , 2003, Seminars in radiation oncology.

[20]  C. N. Coleman,et al.  CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. , 2003, Seminars in radiation oncology.

[21]  C. Cleeland,et al.  When is it justified to treat symptoms? Measuring symptom burden. , 2002, Oncology.

[22]  C. Cleeland,et al.  Assessing symptom distress in cancer patients , 2000 .

[23]  E. Basch,et al.  An evidence-based systemic review Echinacea E. angustifolia DC, E. pallida, E. purpurea by the Natural Standard Research Collaboration. , 2005, Journal of herbal pharmacotherapy.

[24]  C. Cleeland,et al.  Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. , 2000, Cancer.